Alliances

Sequella is committed to leading the industry in commercializing biopharmaceutical products for infectious diseases.  Our business model and corporate strategy closely integrate alliances with product development. We have collaborations with biopharmaceutical companies, healthcare foundations, global health experts, and academic and government institutions.  Through corporate alliances Sequella has advanced an infectious disease product into late-stage clinical trials; gained access to an expanded pipeline portfolio; and combined research and discovery expertise with a partner's complementary commercialization strengths.